Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas

NCT05105412 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped The resolution of DSMB

Conditions

Peripheral T-cell Lymphomas (PTCL)

Interventions

DRUG: Lenalidomide and Gemcitabine (Dose level 11)
DRUG: Lenalidomide and Gemcitabine (Dose level 21)
DRUG: Lenalidomide and Gemcitabine (Dose level 31)
DRUG: Lenalidomide and Gemcitabine (Dose level 41)

Sponsor

National Health Research Institutes, Taiwan

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]